Finding Providers
loading

We found 5 mohs skin cancer surgeons near Norfolk, VA.

Dr. Lawrence Kuo Chang, MD
Specializes in MOHS-Micrographic Surgery
601 Medical Tower
Norfolk, VA
 

Dr. Lawrence Chang's medical specialty is MOHS-micrographic surgery. He has a special interest in cosmetic skin treatment. He honors Medicaid and Medicare insurance. Dr. Chang's education and training includes medical school at the University of Colorado Denver School of Medicine and residency at the University of Iowa Hospitals & Clinics. He has received the distinction of Hampton Roads Super Doctors. Dr. Chang (or staff) is conversant in Mandarin and Korean. Dr. Chang is professionally affiliated with Dermatology Specialists.

Read more

Clinical interests: Cosmetic Skin Treatment

No Photo
Specializes in MOHS-Micrographic Surgery
721 Fairfax Avenue; Suite 200
Norfolk, VA
 

Dr. Bryan Carroll, who practices in Hampton, VA and Norfolk, VA, is a medical specialist in MOHS-micrographic surgery. Dr. Carroll accepts Anthem, Blue Cross/Blue Shield, and Coventry, as well as other insurance carriers. After attending Case Western Reserve University School of Medicine, he completed his residency training at a hospital affiliated with the University of Texas Southwestern Medical Center at Dallas. He is conversant in Spanish. He is affiliated with Sentara Norfolk General Hospital and Hampton VA Medical Center.

Read more
Dr. Brian L Johnson, MD
Specializes in General Practice, Dermatological Immunology, Pediatric Dermatology, Dermatopathology, MOHS-Micrographic Surgery
241 Corporate Boulevard; Suite 215
Norfolk, VA
 

Dr. Brian Johnson's specialties are general practice, pediatric dermatology, and dermatological immunology. He is a graduate of Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine. Dr. Johnson's training includes a residency program at a hospital affiliated with Johns Hopkins University. Areas of particular interest for Dr. Johnson include contact dermatitis, hair problems, and psoriasis. Dr. Johnson has received a 4.5 out of 5 star rating by his patients. He accepts Humana HMO, Humana Bronze, and Humana Catastrophic, as well as other insurance carriers. He speaks Spanish.

Read more

Clinical interests: Psoriasis, Contact Dermatitis, Hair Problems, Skin Issues, Skin of Color

No Photo
Specializes in MOHS-Micrographic Surgery
110 Kingsley Lane; Suite 410
Norfolk, VA
 

Dr. Michael Gross' medical specialty is MOHS-micrographic surgery. The average patient rating for Dr. Gross is 3.0 stars out of 5. Dr. Gross is an in-network provider for several insurance carriers, including MAMSI, Anthem, and Blue Cross/Blue Shield. Before completing his residency at a hospital affiliated with Tulane University, Dr. Gross attended medical school at Tulane University School of Medicine. Dr. Gross has received the following distinction: clinical instructer of the year, ghent family practice residency program. Dr. Gross (or staff) is conversant in Filipino and Spanish. He is professionally affiliated with Chesapeake Regional Medical Center, Children's Hospital of the King's Daughters, and Bon Secours Depaul Medical Center.

Read more
No Photo
Specializes in MOHS-Micrographic Surgery
 

Dr. Bruce Feldman is a physician who specializes in MOHS-micrographic surgery. Dr. Feldman is a graduate of Philadelphia College of Osteopathic Medicine. He is professionally affiliated with VA San Diego Healthcare System (VASDHS).

Read more

Conditions / Treatments

Insurance

Medicare Patient Age

Medicare Patient Conditions

Medicare Patient Ethnicity

Medicare Patient Gender

Medicare Patient Insurance Eligibility

Additional Information

Distinctions

Foreign Language

Online Communication

Practice Affiliation

Credentials

Fellowship

Medical School

Residency

Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.